Top Story

Dna Sequencing Data Analysis Social
Research Grant
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
Featured
Blood Test Samples Lab Social
Clinical Chemistry
ADLM releases guidance for blood lipid assessment, lipoprotein testing
Research Money Social
Research Grant
Seegene, Springer Nature launch PCR innovation program
Latest News
Law Books Gavel Social
European Court rules for Illumina in jurisdictional appeal
September 4, 2024
Layoff Form Sign Social
BioMarin to lay off 225 employees, reorganize programs
August 30, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Breast Mammo Social
University of Eastern Finland researchers develop algorithm for better breast cancer screening
August 23, 2024
Handcuffs Gavel Social
Kickback
Former COO of COVID-19 test distributor sentenced for wire fraud
Financing
BillionToOne secures $140M financing agreement with Oberland Capital
Clinical Chemistry
ADLM releases guidance for blood lipid assessment, lipoprotein testing
Lawsuit
European Court rules for Illumina in jurisdictional appeal
Dna Sequencing Data Analysis Social
Research Grant
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
Immunoassays
Rapid blood test for heart attack holds promise for shorter ED stays
Financing
BillionToOne secures $140M financing agreement with Oberland Capital
Clinical Chemistry
ADLM releases guidance for blood lipid assessment, lipoprotein testing
Heart Ekg Social
Immunoassays
Rapid blood test for heart attack holds promise for shorter ED stays
Collaboration
Hitachi High-Tech, Gencurix forge agreement on cancer diagnostics
Lyme Disease
AI-guided rapid Lyme disease test shows promise for early detection
Guideline
Upcoming lung cancer molecular testing guidelines address 7 questions
More from LabPulse.com
Former COO of COVID-19 test distributor sentenced for wire fraud
By LabPulse.com staff writers
The former chief operating officer (COO) of a COVID-19 testing kit distributor was sentenced to more than six years in federal prison for embezzling more than $1.85 million in company funds.
September 6, 2024
Handcuffs Gavel Social
Rapid blood test for heart attack holds promise for shorter ED stays
By LabPulse.com staff writers
A rapid blood test that can distinguish heart attack in people presenting at emergency departments (EDs) with chest pain has been developed by researchers.
September 5, 2024
Heart Ekg Social
BillionToOne secures $140M financing agreement with Oberland Capital
By LabPulse.com staff writers
Molecular diagnostics firm BillionToOne has signed a $140 million nondilutive financing agreement with Oberland Capital Management.
September 5, 2024
Genetics Dna Money Social
Hitachi High-Tech, Gencurix forge agreement on cancer diagnostics
By LabPulse.com staff writers
Hitachi High-Tech and oncology molecular diagnostics firm Gencurix have formed a strategic partnership aimed at developing cancer diagnostics and testing services.
August 30, 2024
Hands Shaking2 Social
EDX, Caris sign molecular profiling distribution agreement
By LabPulse.com staff writers
Digital diagnostics developer EDX Medical Group and precision medicine company Caris Life Sciences have signed a distribution agreement for Caris' molecular profiling services.
September 3, 2024
Business Handshake Man Social
Lumos Diagnostics extends deal to advance POC liver monitoring test to trials
By LabPulse.com staff writers
Lumos Diagnostics is expanding an existing deal with the Burnet Diagnostics Initiative that will advance a new point-of-care (POC) test for monitoring liver health in an upcoming clinical trial.
August 28, 2024
Liver Social
AI-guided rapid Lyme disease test shows promise for early detection
By LabPulse.com staff writers
A new test under development that uses artificial intelligence (AI) and a format similar to that of at-home COVID-19 tests has been shown to accurately identify Lyme disease within 20 minutes.
August 29, 2024
Ticks Sign Social
Upcoming lung cancer molecular testing guidelines address 7 questions
By Liz Carey
Revised guideline addresses next-generation sequencing and expanded biomarker testing.
August 28, 2024
Lung Cancer Hotspot Social
Qiagen ventures into chronic disease CDx
By LabPulse.com staff writers
Qiagen has expanded its agreement with AstraZeneca beyond oncology.
August 29, 2024
Business Handshake Intelligence Social
FDA approves Illumina IVD kit as CDx
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has approved Illumina's TruSight Oncology Comprehensive cancer biomarker IVD kit for use as a companion diagnostic to match patients to two targeted therapies, Bayer's Vitrakvi and Lilly's Retevmo.
August 27, 2024
Regulatory File Submit Social
Seegene develops two RUO mpox assays
By LabPulse.com staff writers
Seegene has developed two polymerase chain reaction (PCR) test assays for mpox research testing.
August 26, 2024
Monkeypox Virus Social
Trudell Medical to acquire Vyaire Medical's RDx unit
By LabPulse.com staff writers
Medical device developer Trudell Medical has reached an agreement to buy the respiratory diagnostics (RDx) business of Vyaire Medical.
August 27, 2024
Business Men Handshake Social